Department of Neurosurgery, Fontana Medical Center, Fontana, CA.
Neurosurgery Residency Program, Arrowhead Regional Medical Center, Colton, CA.
Perm J. 2020 Dec;25:1-3. doi: 10.7812/TPP/19.164.
New stroke thrombectomy devices have significantly improved recanalization rates in patients with large vessel occlusion. The first pass effect, or complete or near complete recanalization after a single pass of a device, is associated with better outcome. However, it remains unclear whether one technique is superior to the others at first pass recanalization.
The successful recanalization rates of three common techniques: 1) Stent-retriever with the Solitaire or 2) Trevo device, or 3) primary aspiration (PA) with a distal aspiration catheter, were compared across three Kaiser Permanente Southern California Medical Centers over a 5-year period.
Retrospective review of cases between October 2013 and May 2018.
Successful recanalization after a single pass of a device.
Forty-five percent of Solitaire thrombectomies resulted in first pass success, compared with 31% of Trevo and 39% of PA, not statistically significant (p = 0.26). Adjusted for age, gender, and National Institutes of Health Stroke Scale score, the odds of successful recanalization were 1.90 ± 0.72 (CI 0.90-3.99, p = 0.09) for Solitaire compared with Trevo, and 1.41 ± 0.50 (CI 0.70-2.84, p = 0.33) for aspiration compared with Trevo.
In this multi-center cohort, there was no statistical difference in successful first pass recanalization between Solitaire, Trevo, and PA. However, there was a trend towards improved efficacy with the Solitaire device compared to Trevo (OR 1.90, p = 0.09). Additional data are needed to determine the conditions under which design differences may favor one technique over another.
新型取栓装置可显著提高大动脉闭塞患者的再通率。首次通过效果,即单次通过装置后完全或近乎完全再通,与更好的预后相关。然而,目前尚不清楚在首次通过再通方面,哪种技术更具优势。
比较三种常见技术(1)支架取栓联合 Solitaire 或 2)Trevo 装置,或 3)使用远端抽吸导管的直接抽吸(PA))在加利福尼亚州南部的三个 Kaiser Permanente 医疗中心的 5 年期间的首次通过再通率。
2013 年 10 月至 2018 年 5 月间的病例回顾性研究。
单次通过装置后的再通成功。
Solitaire 血栓切除术有 45%的患者首次通过成功,而 Trevo 为 31%,PA 为 39%,无统计学差异(p = 0.26)。校正年龄、性别和 NIHSS 评分后,与 Trevo 相比,Solitaire 成功再通的优势比为 1.90 ± 0.72(CI 0.90-3.99,p = 0.09),与 Trevo 相比,抽吸的优势比为 1.41 ± 0.50(CI 0.70-2.84,p = 0.33)。
在这个多中心队列中,Solitaire、Trevo 和 PA 之间首次通过再通的成功率没有统计学差异。然而,与 Trevo 相比,Solitaire 装置的疗效有改善趋势(OR 1.90,p = 0.09)。需要更多的数据来确定设计差异在何种条件下可能使一种技术优于另一种技术。